New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Scribe Therapeutics Inc.

SCTX

Healthcare Biotechnology

Scribe Therapeutics Inc.’s revenue for fiscal 2025 (year ended December 2025) was $51.2 million.

12.07 1.15 −8.70%

After hours trading: 12.00, down 0.58%, last trade Fri 7:39pm Eastern.

Market cap
$250.4M
P/E
n/m
Fwd P/E FY26e
n/m
Dividend yield
—
F-score
n/a
ROIC
—
Net debt / EBITDA
—
Payout ratio
—
Older periods Dec '25 Mar '26 Jun '26 Sep '26
P/E ratio

+2 more quarters

— 0.00 0.00 0.00
P/S ratio
— 1.84 1.84 10.31
P/FCF ratio
— 0.00 0.00 0.00
P/Operating CF
— (4.75) (4.75) (23.72)
P/B ratio
— 0.00 0.00 2.13
Price to Tangible BV
— 0.00 0.00 2.13
EV/Sales
— 0.36 0.36 3.58
EV/EBITDA
— 0.00 0.00 0.00
EV/Operating CF
— 0.00 0.00 0.00
EV/FCF
— 0.00 0.00 0.00
Quick Ratio
0.94 — 0.56 4.62
Current Ratio
0.97 — 0.57 4.72
Net Debt/EBITDA
— — 4.58 17.26
Debt/Assets
0.00% — 0.00% 0.00%
Debt/Equity
0.00 — 0.00 0.00
Operating CF/Net income
— — — 1.14
Capex/Depreciation
— — — (0.02)
Interest Coverage
— — (34.04) —
Research and Development Expense of Revenue
— — 460.01% 504.83%
Selling, General and Administrative Expense of Revenue
— — 129.82% 259.11%
Intangible Assets out of Total Assets
0.00 — 0.00 0.00
Share Based Compensation of Revenue
— — — 74.27%
Graham Net Nets
— (1.07) (1.07) 0.44
Graham Number
— 0.00 140.31 0.00
Earnings Yield
— (60.70%) (60.70%) (52.93%)
Free Cash Flow Yield
— 0.00% 0.00% 0.00%
Revenue per Share
— 0.91 0.77 0.11
Operating CF per Share
— — — (0.78)
Capex per Share
— — — 0.00
Free Cash Flow per Share
— — — (0.78)
Cash per Share
— — 17.37 12.02
Shareholders Equity per Share
— — (17.97) 8.63
Interest Debt per Share
— — 0.00 0.00
Book value per Share
— — (17.97) 8.63
Free Cash Flow
— — — (11.26)
Working Capital
(2.12) — (33.59) 140.96
Capital Expenditures
— — — (0.01)
Net Current Asset Value
(34.35) — (57.31) 116.13
EV/EBIT
— 0.00 0.00 0.00
Capex to Sales
— — — 0.01
Price to Operating Income
— 0.00 0.00 0.00

Fold the line items

Columns are period end dates · fundamentals updated Nov 18, 2026